US20100098702A1 - Method of treating androgen independent prostate cancer - Google Patents

Method of treating androgen independent prostate cancer Download PDF

Info

Publication number
US20100098702A1
US20100098702A1 US12/561,180 US56118009A US2010098702A1 US 20100098702 A1 US20100098702 A1 US 20100098702A1 US 56118009 A US56118009 A US 56118009A US 2010098702 A1 US2010098702 A1 US 2010098702A1
Authority
US
United States
Prior art keywords
compound
prostate cancer
cells
methylisoindigo
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/561,180
Inventor
Longgui Wang
Simon K. Mencher
James P. McCarron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natrogen Therapeutics International Inc
Original Assignee
Natrogen Therapeutics International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US9728008P priority Critical
Application filed by Natrogen Therapeutics International Inc filed Critical Natrogen Therapeutics International Inc
Priority to US12/561,180 priority patent/US20100098702A1/en
Publication of US20100098702A1 publication Critical patent/US20100098702A1/en
Assigned to NATROGEN THERAPEUTICS INTERNATIONAL, INC. reassignment NATROGEN THERAPEUTICS INTERNATIONAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WANG, LONGGUI, MCCARRON, JAME P., JR., MENCHER, SIMON K.
Abandoned legal-status Critical Current

Links